PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
24.59%
Some net income increase while ZETA is negative at -17.83%. John Neff would see a short-term edge over the struggling competitor.
-3.95%
Both reduce yoy D&A, with ZETA at -0.16%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-17458.82%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
8.34%
SBC growth well above ZETA's 4.52%. Michael Burry would flag major dilution risk vs. competitor’s approach.
205.26%
Well above ZETA's 89.53% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
190.35%
AR growth well above ZETA's 211.65%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-100.26%
Both reduce yoy inventory, with ZETA at -100.00%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-129.13%
Negative yoy AP while ZETA is 43.06%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-131.10%
Both reduce yoy usage, with ZETA at -179.53%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
12.50%
Lower 'other non-cash' growth vs. ZETA's 332.59%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
8.06%
Operating cash flow growth above 1.5x ZETA's 1.23%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
9.95%
Some CapEx rise while ZETA is negative at -73.71%. John Neff would see competitor possibly building capacity while we hold back expansions.
-140.72%
Negative yoy acquisition while ZETA stands at 48.94%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
30.71%
Purchases growth of 30.71% while ZETA is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
37.46%
Liquidation growth of 37.46% while ZETA is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-196.08%
We reduce yoy other investing while ZETA is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
70.05%
Investing outflow well above ZETA's 16.49%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
36.00%
We slightly raise equity while ZETA is negative at -100.00%. John Neff sees competitor possibly preserving share count or buying back shares.
-7.06%
We cut yoy buybacks while ZETA is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.